Skip to main content

Table 5 Comparison between levels of DNMT3A gene expression and NO level before and after treatment

From: Prognostic significance of DNMT3a gene expression and reactive nitrogen species in newly diagnosed Egyptian de novo adult acute myeloid leukemia patients

  

Level of expression

U

P

Low expression

High expression

DNMT3A expression

Before

(n= 22)

(n= 23)

  

 Min.–Max.

18.60–42.30

46.50–83.60

0.000*

<0.001*

 Mean ± SD

29.26 ± 8.26

63.27 ± 11.65

 Median

27.80

61.20

After

(n= 13)

(n= 13)

  

 Min.–Max.

2.96–23.40

5.69–71.20

17.00*

0.001*

 Mean ± SD

10.58 ± 6.68

39.18 ± 21.57

 Median

10.20

43.60

NO Level

Before

(n= 22)

(n= 23)

  

 Min.–Max.

0.53–46.90

3.20–60.90

207.00

0.296

 Mean ± SD

14.14 ± 12.44

17.90 ± 15.21

 Median

9.55

13.40

After

(n= 13)

(n= 13)

  

 Min.–Max.

0.0–26.60

0.0–27.50

83.50

0.959

 Mean ± SD

8.47 ± 6.81

9.15 ± 8.26

 Median

6.20

7.50

  1. U, p: U and P values for Mann-Whitney test
  2. *Signifies statistical significance